EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling

Victor Amajor, Amanda Bwint, Steven L Shein, Janet Hume, Courtney M Rowan, LeeAnne P Flygt, Matthew P Malone, Erin K Stenson, Scott L Weiss, Matt S Zinter, Sujatha Kannan, Mary K Dahmer und 8 weitere

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01736-25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Victor Amajor und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cefepime, Multiple Organ Failure, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to half of critically ill children experience multiple organ dysfunction syndrome (MODS), which worsens outcomes and increases mortality risk. Cefepime is a broad-spectrum antibiotic commonly used in pediatric sepsis, but its pharmacokinetics during MODS has not been evaluated. We performed a prospective, observational study of critically ill children with MODS who were administered cefepime and collected up to 15 whole blood samples over 3 days using volumetric absorptive microsampling (VAMS). We performed nonlinear mixed-effects modeling to develop a population PK model for cefepime in children with MODS. We then reran our final population PK model using estimated plasma concentrations based on a 0.58:1 VAMS:plasma ratio derived ex vivo . A two-compartment model with allometric scaling best described the data. Estimated glomerular filtration rate and age were significant covariates on total body clearance and central volume, respectively. Final model parameter estimates for clearance and central volume in VAMS were 5.14 L/h and 20.5 L, respectively, for a 36-kg child. Estimates for clearance and central volume in plasma were 2.97 L/h and 11.51 L, respectively. We provide the first population PK model of cefepime in critically ill children with MODS based on VAMS, along with estimated plasma PK derived from VAMS data. Our study demonstrates the feasibility of using a novel microsampling approach to evaluate antimicrobial PK in critically ill children and provides the groundwork to better understand how this approach can optimize treatment and monitoring in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefepimeMultiple Organ FailureAnti-Bacterial AgentsHumansCritical IllnessMaleFemaleChild, PreschoolProspective StudiesChildInfantThird Generation CephalosporinsAdolescent

Stichwörter der Autor:innen

antibioticspharmacokineticssepsis

Substanzen

CefepimeAnti-Bacterial AgentsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Critical Care Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
  • Division of Critical Care Medicine, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, USA.
  • Division of Critical Care Medicine, Indiana University School of Medicine at Riley Children's Health, Indianapolis, Indiana, USA.
  • Division of Critical Care Medicine, University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, USA.
  • Division of Critical Care Medicine, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, USA.

ORCID-Profile: Nathaniel J Rhodes, Marc H Scheetz, Kevin J Downes

Förderung

  • NIGMS NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute of General Medical Sciences

Zitieren

APA

Amajor, V., Bwint, A., Shein, S. L., Hume, J., Rowan, C. M., Flygt, L. P., Malone, M. P., Stenson, E. K., Weiss, S. L., Zinter, M. S., Kannan, S., Dahmer, M. K., Nofziger, R. A., Pai, M. P., Zuppa, A. F., Rhodes, N. J., Hall, M. W., Scheetz, M. H., Downes, K. J., & Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network (2026). Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01736-25

Vancouver

Amajor V, Bwint A, Shein SL, Hume J, Rowan CM, Flygt LP, et al. Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01736-25

BibTeX
@article{Amajor2026,
  author = {Amajor, Victor and Bwint, Amanda and Shein, Steven L and Hume, Janet and Rowan, Courtney M and Flygt, LeeAnne P and Malone, Matthew P and Stenson, Erin K and Weiss, Scott L and Zinter, Matt S and Kannan, Sujatha and Dahmer, Mary K and Nofziger, Ryan A and Pai, Manjunath P and Zuppa, Athena F and Rhodes, Nathaniel J and Hall, Mark W and Scheetz, Marc H and Downes, Kevin J and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network},
  title = {Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01736-25}
}
Kostenlos starten →